Tracking

Thursday 5 August 2021

CCC publication: Overall survival in patients who received checkpoint inhibitors after completing tebentafusp in a phase 3 randomized trial of firstline metastatic uveal melanoma

Citation: Journal of Clinical Oncology. 2021, 39(15)
Author: Orloff M.; Carvajal R.D.; Shoushtari A.N.; Sacco J.J.; Schlaak M.; Watkins C.; Abdullah S.E.; Goodall H.; Butler M.O.